Member Info for Kong1

Jive

The upcoming data from previous cohorts and possibly some of cohort 7 will be fascinating to see.

I believe they included the soft sarcoma patient on purpose to see what effaccy may be seen, and I also think they will include one or two more in this cohort.

Reason being, due to now missing P1b I think this will give them a better insight on how to proceed with dose levels and days / weeks between doses

You two need to get married ffs

Wearegroot

The $1.5b per annum sales are just from Europe and North America.

Sales from the rest of the world are not included in your calculations so it may be much higher than that.

But I’d say at least your predications yes

My thoughts is MTD hasn’t been found yet.

They may have an idea, but how I’m looking at it.

Is I think at least 2 doses have been given so far.

Possibly 3 !!

If by the 2nd dose MTD had been found then we would have had an RNS and the trial stopped.

We haven’t so, Either dose number 3 is going to be given or it has already.

That will be 954mg of AVA6000 administered in this cohort

Does anyone know how AVA6000 is administered?

Wearegroot

I’ve known C2H for over a year now.

I speak in the phone to him most weekends. Yes he is very much a doctor.

I brought Avacta to his attention several weeks ago due to the fact his sister was in late stage breast cancer.

He buried her 2 weeks ago, now shut TFU

He hasn’t had the stomach to look into this much and that’s why.

Sorry to all other posters but it had to be said

WEAREGROOT

I personally do know C2H5OH and yes he is a doctor.

Hi C2H5OH

AS did say in the AGM podcast, That after the cohorts are finished in this trial.

Avacta will share all the data in much more detail about all the information they have achieved through this trial.

I`m pretty sure it will be very comprehensive.

The problem with this share is the seller that just keeps selling chunks

Once he’s gone it should rise a little

Is something bubbling?

If Tintra gets re listed, then bet your bottom dollar it will make you a pretty penny.

we Just have to hope RS has got our backs covered.

Seller still with us

For all these buys and SP dosent move

They must be working a huge sell

And still a large seller about

Flava

There may be still more to come yet

Hopefully once the seller has gone the sp will rise

I notice some good buys coming through at the moment

Somebody seems hell bent on dumping a large volume of shares

Jive-turkey

We must also realise that even if the exact same dose of AVA6000 is given over the same number of cycles of standard doxorubicin

A far greater % of the doseage of AVA6000 will be absorbed by the tumour thus giving a greater effacy .

A larger dose over a longer period should be even better.

AS said in the agm podcast that standard of care today is a very small hurdle to over cone !!!

It’s mind boggling what is going to be achieved shortly

Hi DonaldTrumpwig

your comment :-

Yes, we have to complete P1b to meet regulatory compliance however we mustn’t forget that efficacy is already confirmed because, as the saying goes, dox will be dox.

I think efficacy was confirmed when Alastair said,

Several patients from previous cohorts are still recieving treatments and their cancers haven`t progressed. !!!

These are terminally ill patients that have had their cancers halted. To what extent I do not know, but I really do hope we get more info about these patients when we get results from cohort 6

Moniman

You need to do more homework as clearly you Haven’t

AS spoke at sometime about this issue in the AGM podcast as well as the share price. All implications etc